4.7 Review

Evidence on the Human Health Effects of Low-Level Methylmercury Exposure

Journal

ENVIRONMENTAL HEALTH PERSPECTIVES
Volume 120, Issue 6, Pages 799-806

Publisher

US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
DOI: 10.1289/ehp.1104494

Keywords

birth outcomes; cardiovascular disease; epidemiology; health outcomes; low-level exposure; metals; methylmercury; neurologic outcomes

Funding

  1. National Institute of Environmental Health Sciences, National Institutes of Health (NIH) [P42 ES007373, P20 ES018175, R01 ES014864, R01 ES09797, P30 ES000002, R01 ES016314]
  2. National Institute of Diabetes and Digestive and Kidney Diseases, NIH [P30 DK040561]
  3. U.S. Environmental Protection Agency (EPA) [RD-83459901]

Ask authors/readers for more resources

BACKGROUND: Methylmercury (MeHg) is a known neurotoxicant. Emerging evidence indicates it may have adverse effects on the neurologic and other body systems at common low levels of exposure. Impacts of MeHg exposure could vary by individual susceptibility or be confounded by beneficial nutrients in fish containing MeHg. Despite its global relevance, synthesis of the available literature on low-level MeHg exposure has been limited. OBJECTIVES: We undertook a synthesis of the current knowledge on the human health effects of low-level MeHg exposure to provide a basis for future research efforts, risk assessment, and exposure remediation policies worldwide. DATA SOURCES AND EXTRACTION: We reviewed the published literature for original human epidemiologic research articles that reported a direct biomarker of mercury exposure. To focus on high-quality studies and those specifically on low mercury exposure, we excluded case series, as well as studies of populations with unusually high fish consumption (e. g., the Seychelles), marine mammal consumption (e. g., the Faroe Islands, circumpolar, and other indigenous populations), or consumption of highly contaminated fish (e. g., gold-mining regions in the Amazon). DATA SYNTHESIS: Recent evidence raises the possibility of effects of low-level MeHg exposure on fetal growth among susceptible subgroups and on infant growth in the first 2 years of life. Low-level effects of MeHg on neurologic outcomes may differ by age, sex, and timing of exposure. No clear pattern has been observed for cardiovascular disease (CVD) risk across populations or for specific CVD end points. For the few studies evaluating immunologic effects associated with MeHg, results have been inconsistent. CONCLUSIONS: Studies targeted at identifying potential mechanisms of low-level MeHg effects and characterizing individual susceptibility, sexual dimorphism, and nonlinearity in dose response would help guide future prevention, policy, and regulatory efforts surrounding MeHg exposure.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available